About Us
Mylan [
mī-l
uhn] is one of the world’s leading quality generic
and specialty pharmaceutical companies. The company offers one of the
industry’s broadest and highest quality product portfolios, a robust product
pipeline and a global commercial footprint through operations in more than 90
countries. Employing approximately 15,000 people, Mylan has attained leading
positions in key international markets through its wide array of dosage forms
and delivery systems, significant manufacturing capacity, global scale and a
committed focus on quality and customer service.
Through its controlling interest in
Matrix Laboratories Limited, Mylan has direct access to the
second-largest active pharmaceutical ingredient (API) manufacturer in the
world. This relationship makes Mylan one of only two global generic companies
with a comprehensive, vertically integrated supply chain.
Dey L.P., Mylan’s
fully integrated specialty business, provides the company with innovative and
diversified opportunities in the respiratory and allergy therapeutic areas.
An Established Market Leader
Mylan today holds leading positions in 13 of the most competitive generics
markets across the globe.*
|
Australia (No. 1)
Belgium (No. 2)
France (No. 1)
Holland (No. 5)
Ireland (No. 4)
|
Italy (No. 3)
Japan (No. 4)**
Portugal (No. 1)
New Zealand (No. 1)
Scandinavia (No. 4)
|
Spain (No. 3)
United Kingdom (No. 2)
United States (No. 2)
|
* as of March 15, 2008
** largest international company
|